Your partner in computational drug design
Silicos-it is a Belgian consultancy company, founded in 2010 and specialised in computational drug design. We provide support in all aspects of modern computational drug design, including virtual screening, molecular dynamics applications, and state-of-the-art structure-activity machine learning models. In addition, we are also involved in writing open source software tools.
Since 2013, a strong relation with the University of Antwerp (UA) was established. Because of this, we can provide you with a complete set of solutions to all your questions related to computational drug design. This may include service work under the wings of the UA, submission and execution of a VLAIO project with the UA as academic partner, or some well-defined fee-for-service projects with Silicos-it as the commercial partner.
Do you like to find out more of what we can do for you? Then have a look at the research examples page on this website for ideas and opportunities. And the who are we page gives you insight into our history and where we are right now.
Do you think we can help you? We are open to many forms of collaboration. Therefore, do not hesitate to contact us to discuss your potential research ideas. Maybe it is the beginning of a mind-blowing research collaboration!
Our latest post
-
First Symposium on Computational Chemistry in Flanders: Computational Design of Drugs and Materials
Together with Prof. Frederik Tielens (VUB) and Christophe De Bie (UA), we are organising a minisymposium on computational design. On December 12, 2025, this minisymposium brings together leading researchers in the fields of computational drug discovery and materials science. Through a series of invited talks, we aim to explore current advances and foster dialogue between disciplines. Invited speakers are Dr. Sandro Boland (CISTIM / KU Leuven), Drs. Joep Wals (University of Antwerp), Dr. Edgar Jacoby (J&J), Dr. Maria Cecilia Oliveira (UA), Prof. Jeremy Harvey (KU Leuven), and Prof. Mark Saeys (Ghent University).